Chemours Q1 Sales $1.350B Beat $1.349B Estimate
Portfolio Pulse from Benzinga Newsdesk
Chemours (NYSE:CC) reported Q1 sales of $1.350 billion, slightly beating the analyst consensus estimate of $1.349 billion by 0.04%. However, this represents a 12.11% decrease from the $1.536 billion sales reported in the same period last year.
April 30, 2024 | 8:29 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Chemours reported a slight beat on Q1 sales estimates but saw a significant year-over-year decrease.
While Chemours beating sales estimates is positive, the significant year-over-year decrease in sales is likely to concern investors and could negatively impact the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100